This page shows the latest PSPs news and features for those working in and with pharma, biotech and healthcare.
The investigational treatment, UCB0107, is a monoclonal antibody drug being developed by UCB as a potential treatment for patients with tauopathies, such as progressive supranuclear palsy (PSP) and Alzheimer’s disease. ... UCB is already developing
The three targets at the centre of the collaboration with Ireland-based Prothena include: tau protein, already a focus in Alzheimer’s research and other conditions like progressive supranuclear palsy (PSP);
Also testing antibody in rare condition PSP, for which FDA has awarded fast-track designation. ... The US FDA has awarded ABBV-8E12 fast-track designation for PSP, he said.
The first-in-class therapy - called C2N-8E12 or ABBV-8E12 - is being tested in patients with the rare neurodegenerative disorder progressive supranuclear palsy (PSP), which affects around 20, 000 people ... The phase I study is a single ascending dose
IPN007 is being developed in the first instance for progressive supranuclear palsy (PSP), a serious neurodegenerative disorder that progresses much more quickly than Alzheimer's but is also characterised by tau
Best use of Art Direction. 'PSP Scale', Invega for Janssen, by Torre Lazur McCann. ... Healthcare Professional, Film. 'PSP Scale', Invega for Janssen, by Torre Lazur McCann.
More from news
Approximately 0 fully matching, plus 9 partially matching documents found.
Community support forums. It’s important to stress the need for flexibility and personalisation in PSPs. ... Beyond the pill. If designed correctly, with patient needs in mind, PSPs have every chance of succeeding.
Thorough PSP evaluation is rare (for multiple reasons) but is essential to enable the field to move forwards. ... We love the opportunity PSP development gives us to hear what patients and caregivers need and to support them to grow.
specific devices, such screen readers, which may be used to access the PSP. ... PSPs provide an exciting opportunity for personalised care for patients living with rare diseases.
But these areas for improvement should not detract from the massive opportunities PSPs present.”. ... PSPs are a great way of empowering them to do that,” added Maule.
By Charlotte Maule. Educating and empowering patients. The benefits of patient support programmes (PSPs) are many. ... Improving patient engagement can only lead to better outcomes for all stakeholders – and PSPs can amplify this.
More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.
One report by the NHS Confederation highlights the key barriers to PSP uptake, noting lack of awareness of PSPs for both patients and healthcare professionals (HCPs see below) as a key ... Seb Tucknott CEO &Co-founder IBD Relief. If finding PSPs through
Live video has a number of practical applications with both patient and professional audiences, for example as part of Patient Support Programming (PSPs) where patient experts get to share their disease
Patients, payers and healthcare professionals have high expectations for patient support programmes (PSPs). ... Discover 5 ways to make your PSP a big success:. Get invaluable insights based on 16 years’ experience of creating successful PSPs.
Our client’s main objectives were to:. Design and build out a new patient support program (PSP) for patients with psoriasis. ... Determine the most important aspects to focus on and ensure a patient-centric approach to their PSP.
The Impetus InSite Platform can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to use it for virtually launching a brand! Over the last year, we’ve learned
More from PMHub
Approximately 4 fully matching, plus 11 partially matching documents found.
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...